Marc Frahm
Stock Analyst at TD Cowen
(4.92)
# 219
Out of 4,698 analysts
411
Total ratings
56.7%
Success rate
26.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marc Frahm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintained: Buy | n/a | $73.02 | - | 3 | Aug 17, 2026 | |
| CRDF Cardiff Oncology | Maintained: Hold | $1.05 | $0.963 | +9.03% | 17 | Aug 12, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | n/a | $3.55 | - | 15 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $205 | $203.71 | +0.71% | 27 | Aug 10, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | n/a | $31.04 | - | 3 | Aug 10, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | n/a | $52.52 | - | 25 | Aug 9, 2026 | |
| PBYI Puma Biotechnology | Maintained: Hold | $5 → $6 | $8.83 | -32.05% | 12 | Aug 7, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | n/a | $2.02 | - | 16 | Aug 5, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $33.56 | - | 26 | Aug 3, 2026 | |
| INCY Incyte | Maintained: Buy | $124 → $138 | $120.16 | +14.85% | 72 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.34 | - | 26 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.95 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $16.97 | -11.61% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.12 | - | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.42 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.50 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $117.39 | - | 22 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.17 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.029 | n/a | 19 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.22 | n/a | 8 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $115.96 | n/a | 10 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $150,000.00 | n/a | 6 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.09 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.05 | n/a | 3 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $37.93 | n/a | 5 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,180.16 | n/a | 1 | Jan 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $347.48 | n/a | 6 | Dec 4, 2018 |
Nektar Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: n/a
Current: $73.02
Upside: -
Cardiff Oncology
Aug 12, 2026
Maintained: Hold
Price Target: $1.05
Current: $0.963
Upside: +9.03%
Sana Biotechnology
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $3.55
Upside: -
Revolution Medicines
Aug 10, 2026
Reiterated: Buy
Price Target: $205
Current: $203.71
Upside: +0.71%
Damora Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: n/a
Current: $31.04
Upside: -
Scholar Rock Holding
Aug 9, 2026
Maintained: Buy
Price Target: n/a
Current: $52.52
Upside: -
Puma Biotechnology
Aug 7, 2026
Maintained: Hold
Price Target: $5 → $6
Current: $8.83
Upside: -32.05%
Black Diamond Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.02
Upside: -
Agios Pharmaceuticals
Aug 3, 2026
Maintained: Buy
Price Target: n/a
Current: $33.56
Upside: -
Incyte
Jul 28, 2026
Maintained: Buy
Price Target: $124 → $138
Current: $120.16
Upside: +14.85%
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $20.34
Upside: -
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $1.95
Upside: -
May 8, 2026
Rated: Hold
Price Target: $15
Current: $16.97
Upside: -11.61%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $16.12
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.42
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.50
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $117.39
Upside: -
Nov 13, 2025
Maintained: Buy
Price Target: n/a
Current: $9.17
Upside: -
Nov 14, 2024
Maintained: Buy
Price Target: n/a
Current: $0.029
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $115.96
Upside: n/a
Mar 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $150,000.00
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $3.09
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $2.05
Upside: n/a
Feb 26, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $37.93
Upside: n/a
Jan 7, 2019
Downgraded: Hold
Price Target: n/a
Current: $1,180.16
Upside: n/a
Dec 4, 2018
Maintained: Buy
Price Target: n/a
Current: $347.48
Upside: n/a